gabexate has been researched along with Blunt Injuries in 1 studies
Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mercantini, P | 1 |
| Virgilio, E | 1 |
| Bocchetti, T | 1 |
| Capurso, G | 1 |
| Nava, AK | 1 |
| Ziparo, V | 1 |
1 other study available for gabexate and Blunt Injuries
| Article | Year |
|---|---|
Is entirely conservative management a correct strategy for hemodynamically stable patient with a grade IV blunt pancreatic injury?
Topics: Accidents, Traffic; Acetaminophen; Combined Modality Therapy; Female; Follow-Up Studies; Gabexate; G | 2011 |